Integrated Pharma Services Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Integrated Pharma Services's estimated annual revenue is currently $930k per year.(i)
  • Integrated Pharma Services's estimated revenue per employee is $155,000

Employee Data

  • Integrated Pharma Services has 6 Employees.(i)
  • Integrated Pharma Services grew their employee count by -14% last year.

Integrated Pharma Services's People

NameTitleEmail/Phone
1
President and Chief Science OfficerReveal Email/Phone
2
VP & Chief Operating OfficerReveal Email/Phone
3
Laboratory ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M2-60%N/AN/A
#2
$2.9M38-31%$17.5MN/A
#3
$2.9M38-33%$10.5MN/A
#4
$19.8M1280%$69.4MN/A
#5
$9.6M62-15%N/AN/A
#6
$1.4M90%N/AN/A
#7
$2.5M160%N/AN/A
#8
$7.4M480%N/AN/A
#9
$0.2M1-83%N/AN/A
#10
$1.7M1122%N/AN/A
Add Company

What Is Integrated Pharma Services?

Integrated Pharma Services (IPS) is an Award-Winning Contract Research Organization (CRO) and Reliable Partner to potential customers. IPS employs a uniquely tailored approach for providing scientific solutions to clients. PhD level scientists troubleshoot, develop and conduct laboratory testing such as antimicrobial, biofilm, bacteriophage, and device evaluations. In addition, we provide scientific consultation and partner with you on grant submissions. IPS has a strong scientific reputation and track record of providing customers the supporting data needed to advance their candidate therapeutics and diagnostics. Integrated Pharma Services has partnerships across the country with our primary laboratories located in Frederick, Maryland. For more information, please contact Dr. Mina Izadjoo at 301-204-4201.

keywords:N/A

N/A

Total Funding

6

Number of Employees

$930k

Revenue (est)

-14%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M6-14%N/A
#2
$0.4M6-14%N/A
#3
$0.4M6-14%N/A
#4
$0.4M6N/AN/A
#5
$0.4M60%N/A